Roivant Sciences ROIV Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Roivant Sciences’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Roivant Sciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Roivant Sciences's financing cash flow?
- Roivant Sciences (ROIV) reported financing cash flow of $328.19M in Q4 2025.
- How has Roivant Sciences's financing cash flow changed year-over-year?
- Roivant Sciences's financing cash flow increased by 220.2% year-over-year, from -$272.95M to $328.19M.
- What is the long-term trend for Roivant Sciences's financing cash flow?
- Over 3 years (2021 to 2024), Roivant Sciences's financing cash flow has grown at a 57.0% compound annual growth rate (CAGR), from $315.21M to -$1.22B.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.